Related Experiment Video
Updated: Apr 29, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Principles and pitfalls in the differential diagnosis and management of childhood obesities
Gabriel Á Martos-Moreno1, Vicente Barrios1, María T Muñoz-Calvo1
1Department of Pediatrics and Pediatric Endocrinology, Hospital Infantil Universitario Niño Jesús; Instituto de Investigación La Princesa; Department of Pediatrics, Universidad Autónoma de Madrid; CIBER Fisiopatología Obesidad y Nutrición; Instituto de Salud Carlos III, Madrid, Spain.
Insights
Childhood obesity is a growing epidemic. Recognizing diverse "obesities" and utilizing genetic, genomic, and metabolomic diagnostics are crucial for personalized pediatric care.
Area of Science:
- Pediatrics
- Endocrinology
- Genetics
Background:
- Childhood obesity is the most prevalent chronic disease in Western countries, leading to increased comorbidities.
- Lifestyle factors contribute to energy imbalance, but genetic background significantly influences obesity risk.
- Understanding diverse pathophysiologic bases of obesity is essential.
Purpose of the Study:
- To highlight the increasing prevalence of childhood obesity and associated comorbidities.
- To emphasize the need to differentiate between various causes of obesity.
- To guide pediatricians in diagnostic and management approaches for childhood obesity.
Main Methods:
- Review of current understanding of obesity etiology, including lifestyle and genetic factors.
- Discussion of monogenic, syndromic, and endocrine-related obesity.
- Emphasis on clinical history, physical examination, and advanced diagnostic studies.
Main Results:
- Obesity is not a single entity but encompasses diverse conditions with different pathophysiologies.
- Genetic, genomic, and metabolomic studies are vital for accurate diagnosis.
- Cognitive behavioral therapy is a fundamental treatment component.
Conclusions:
- Pediatricians must recognize "obesities" as distinct diseases requiring tailored diagnostic and management strategies.
- Personalized medicine approaches, including genetic insights, are key for future obesity treatment.
- Further research into potential pharmacologic targets is needed for translational medicine.
Abstract:
Obesity is currently the most prevalent chronic childhood disease in Western countries. It is one of the most frequent consultations in general pediatrics and is even more common in pediatric endocrinology. As might be predicted, the prevalence of obesity-associated comorbidities is also increasing in children and adolescents. It is widely accepted that this increase in obesity results from an imbalance between energy intake and expenditure, with an increase in positive energy balance being closely associated with the current lifestyle in Western countries. However, there is increasing evidence indicating that an individual's genetic background is important in determining obesity risk. The physiologic mechanisms controlling appetite and energy expenditure are being revealed in part because of the identification of new causes of human monogenic, syndromic, and endocrine-related obesity. Thus, it is no longer appropriate to talk about obesity, but rather about "obesities" or "different diseases causing obesity," because their pathophysiologic bases differ. Moreover, these obesities require different diagnostic and management approaches. The pediatrician must be aware of this issue and focus the clinical history and physical examination toward specific clinical signs and symptoms to better exploit the available diagnostic and therapeutic resources when facing a child with obesity. Genetic, genomic, and metabolomic studies are often necessary to obtain a more appropriate diagnosis. Cognitive behavioral therapy is fundamental in obese children. The identification of potential targets will hopefully result in new pharmacologic approaches for translational and personalized medicine for obesity in the near future.
Related Concept Videos
Obesity
Drug Dosing: Obese Patients
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Diabetes: Symptoms, Diagnosis, and Complications
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...

